Enhancing global access to cancer medicines

Globally, cancer is the second leading cause of death, with numbers greatly exceeding those for human immunodeficiency virus/acquired immunodeficiency syndrome, tuberculosis, and malaria combined. Limited access to timely diagnosis, to affordable, effective treatment, and to high‐quality care are ju...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	CA: a cancer journal for clinicians 2020-03, Vol.70 (2), p.105-124
Hauptverfasser:	Cortes, Javier, Perez‐García, Jose Manuel, Llombart‐Cussac, Antonio, Curigliano, Giuseppe, El Saghir, Nagi S., Cardoso, Fatima, Barrios, Carlos H., Wagle, Shama, Roman, Javier, Harbeck, Nadia, Eniu, Alexandru, Kaufman, Peter A., Tabernero, Josep, García‐Estévez, Laura, Schmid, Peter, Arribas, Joaquín
Format:	Artikel
Sprache:	eng
Schlagworte:	antineoplastic agents Cancer drug regulation Health care health services accessibility HIV Human immunodeficiency virus immunomodulation Malaria Medical personnel Oncology price Radiation therapy research design Surgery Tuberculosis
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!